Telehealth Disclaimer

Last Updated: Aug 22, 2025

PURPOSE AND SCOPE

The telehealth services made available through PeptideCo, Inc. (“PeptideCo, Inc.,” “we,” “us,” or “our”) are provided by Arora Health & Aesthetics, LLC, an independent medical practice, and are strictly limited to safety assessments and medication recommendations conducted by licensed healthcare providers in the states where they are authorized to practice. PeptideCo, Inc. does not itself provide medical or clinical services. Telehealth consultations are provided solely for health optimization purposes and do not include diagnosis, treatment, or management of general medical conditions. The provider may review additional health data voluntarily uploaded by members, but strictly for the purpose of assessing medication safety and making adjustments to medication recommendations. The provider is not the member’s primary care provider and does not establish a traditional doctor-patient relationship.

CONSENT AND RISK ACCEPTANCE

By scheduling a telehealth consultation or selecting an asynchronous review, the member consents to the telehealth services provided by PeptideCo, Inc.. Members acknowledge and accept all risks associated with the use of medications based on disclosed medical history and health information. PeptideCo, Inc. does not assume responsibility for adverse effects arising from undisclosed medical conditions, medication interactions, or incomplete or inaccurate health information provided by the member. Members are solely responsible for the accuracy and completeness of any health data they choose to upload. PeptideCo, Inc. and its affiliates do not verify the accuracy of such data and shall not be liable for adverse outcomes resulting from incomplete or inaccurate disclosures. Members are required to disclose all current medications, supplements, and relevant health conditions to ensure accurate medication recommendations.


Telehealth services provided by PeptideCo, Inc. are based solely on the information disclosed by members. The Protocole is not liable for adverse outcomes resulting from incomplete, inaccurate, or undisclosed health information.

STATE-SPECIFIC TELEHEALTH LIMITATIONS

Telehealth services are available to members located in states where the licensed providers of Arora Health & Aesthetics, LLC are authorized to practice. Members must confirm their physical location at the start of each telehealth session or asynchronous review. If a member is located in a state where the treating provider is not licensed, the session will be terminated immediately and rescheduled once eligibility is confirmed. Arora Health & Aesthetics, LLC and PeptideCo, Inc. reserve the right to terminate telehealth services if a member fails to disclose relevant health information, misrepresents their health status or physical location, or attempts to misuse telehealth services for purposes beyond medication safety assessments. Telehealth services are not provided to members located, whether permanently or temporarily, in states where the treating provider is not licensed.

EMERGENCY AND URGENT CARE DISCLAIMER

PeptideCo, Inc. does not provide urgent care, emergency services, ongoing medical management, or primary medical care through telehealth. However, members are entitled to quarterly check-ins with the concierge team to review medication protocols and overall health optimization progress. The concierge team may provide medication recommendations based on member feedback and general health optimization goals; however, such recommendations are not to be construed as medical advice, diagnosis, or treatment. All medication protocols must be confirmed by the physician solely for safety and dosing purposes. These check-ins are not medical consultations but may result in a request for further analysis by the physician, strictly limited to medication safety assessments and potential adjustments to medication protocols. The physician does not establish a traditional doctor-patient relationship and will not provide follow-up care beyond the scope of medication safety assessments and recommendations. In the event of a suspected adverse reaction to a medication protocol, members are advised to discontinue use immediately and seek emergency medical care. PeptideCo, Inc. does not provide emergency support or urgent care for adverse reactions or complications arising from medication use. Members are instructed to call 911 or contact their primary care provider for immediate assistance.

QUARTERLY CHECK-INS AND FOLLOW-UP REQUESTS

Members are entitled to quarterly check-ins with the concierge team to review medication protocols and overall health optimization progress. These check-ins are not medical consultations and do not establish a doctor-patient relationship. If the concierge team identifies a need for further analysis by the physician, a telehealth session may be requested, strictly limited to medication safety assessments and protocol adjustments.

PAYMENT AND INSURANCE

Telehealth consultations are included in the membership fee and are not billed separately. PeptideCo, Inc. does not accept insurance for telehealth services. All telehealth services are self-pay only.

DATA PRIVACY AND COMMUNICATION

Telehealth consultations are not recorded, and all communications are conducted through secure, encrypted channels. However, PeptideCo, Inc. cannot guarantee the security of data transmitted through unencrypted methods, such as email or SMS. Members are advised to use secure channels for sharing sensitive health information. However, PeptideCo, Inc. cannot guarantee the security of data transmitted via email, SMS, or other unencrypted communication methods. Members are advised to use secure methods for sharing sensitive health information.

LIMITATION OF LIABILITY

PeptideCo, Inc., its physicians, employees, and affiliates shall not be liable for any direct, indirect, incidental, or consequential damages arising from the use of telehealth services, including but not limited to adverse reactions to medications, miscommunication of health information, or missed diagnoses. By accessing telehealth services, members expressly waive any claims against PeptideCo, Inc. arising from the use or misuse of telehealth services, including but not limited to claims related to missed diagnoses, incomplete or inaccurate health disclosures, delays in care, or miscommunication of health information.

BUSINESS INFORMATION

The Protocole (PeptideCo, Inc.)
148 Lafayette, 04-106
New York, NY 10013, US
Phone: +1 (415) 404-8283
Email: concierge@theprotocole.com

Curious but not quite ready to dive in?

We’d love to connect.

© 2026 The Protocole. All rights reserved. The Protocole facilitates access to telehealth services provided by licensed healthcare professionals. Prescription medications are available only following an appropriate clinical evaluation and when prescribed. Compounded medications are not FDA-approved. Individual results vary.

© 2026 The Protocole. All rights reserved. The Protocole facilitates access to telehealth services provided by licensed healthcare professionals. Prescription medications are available only following an appropriate clinical evaluation and when prescribed. Compounded medications are not FDA-approved. Individual results vary.

© 2026 The Protocole. All rights reserved. The Protocole facilitates access to telehealth services provided by licensed healthcare professionals. Prescription medications are available only following an appropriate clinical evaluation and when prescribed. Compounded medications are not FDA-approved. Individual results vary.

A PROTOCOLE. NOT A TREND.
A PROTOCOLE. NOT A TREND.
A PROTOCOLE. NOT A TREND.